AVITA Medical, Inc.
AVITA Medical (Nasdaq: RCEL) develops and commercializes medical technologies and wound care products for acute wounds arising from burns, traumatic injuries and surgical procedures. Its portfolio includes RECELL, an autologous cell-harvesting system that enables clinicians to prepare a patient’s skin cells at the… From the company’s description.
Over the twelve months to Sep 30, 2026, AVITA Medical, Inc. reported revenue of $84.68M, up 17.0% from a year earlier, and a net loss of $36.12M. Its operating margin was −33.9%, and operations used $19.72M in cash. In fiscal 2025, it reported revenue of $71.61M, up 11.5% from fiscal 2024, and a net loss of $48.59M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What AVITA Medical, Inc. does
In the company’s own words
AVITA Medical (Nasdaq: RCEL) develops and commercializes medical technologies and wound care products for acute wounds arising from burns, traumatic injuries and surgical procedures. Its portfolio includes RECELL, an autologous cell-harvesting system that enables clinicians to prepare a patient’s skin cells at the point of care and apply them as a spray to treat thermal burns and full-thickness skin defects; PermeaDerm, a biosynthetic wound matrix; and Cohealyx, a collagen-based dermal matrix for wound bed preparation. Customers include hospitals, burn centers, and trauma and surgical centers, with international sales conducted through distributors. RECELL is the cornerstone of the business, complemented by products that support wound coverage, preparation and closure; the company reports one business segment. AVITA Medical evolved from an Australian-founded company, redomiciled to the United States in 2020, and expanded its portfolio through distribution and development agreements for PermeaDerm and Cohealyx. It employed approximately 226 people as of December 31, 2025. Its website is www.avitamedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- VALENCIA, CA
- Fiscal year end
- December
- CIK
- 1762303
- SIC
- 3841
Financial performance, year by year
Fiscal 2020–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns AVITA Medical, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · AVITA Medical, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do AVITA Medical, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of AVITA Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in AVITA Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”